Introduction
The opioid crisis is a complex public health issue that has increased overdose mortality and other health consequences. From 1999 to 2014, the number of reported overdose deaths rose three times (Vadivelu et al., 2018). Meanwhile, Saloner et al. (2018) reported that the number of opioid-related deaths in 2016 reached 42,000.
Approximately 6% of the population of the US suffers from opioid abuse (Stoicea et al., 2019). In this sense, addiction and opioid abuse have significant societal implications, including economic and social consequences (Lim et al., 2022). Public health initiatives that focus on lowering overdose risk show enormous potential, but executing these approaches needs policies that are anchored in a thorough understanding of the epidemic’s causes.
Thus, this research paper will examine the opioid crisis and the several elements that contribute to its emergence and persistence. The paper will look at the neuroscience of addiction and the difficulties in treating opioid addiction, as well as the significance of medication-assisted therapy and behavioral treatments. To answer the research question, the paper will examine the present situation of the opioid crisis as well as the current prevention and treatment strategies. Overall, this study aims to give insights into how to enhance opioid addiction prevention, treatment, and management in light of the many elements that contribute to its genesis and persistence. By evaluating the present state of the crisis and providing feasible remedies, this study contributed to ongoing efforts to solve this important public health matter.
Neurobiology of Addiction
Biology
Opioid addiction is a complicated disease that impacts people physically, mentally, and socially. Understanding addiction’s neurobiology is critical for establishing successful prevention and treatment techniques. Opioids act through a complex group of receptors and opioid peptides. There are mu, kappa, and delta receptors activated by one of three groups of endogenous opioid peptides (Moningka et al., 2019). These receptors are involved in brain processes like reward, stress, and analgesic processes (Moningka et al., 2019).
Thus, exogenous alkaloid opiates such as morphine, heroin, and other synthetic opioids can also activate opioid receptors (Moningka et al., 2019). Opioid consumption causes the brain to produce dopamine, a chemical linked with pleasure and reward, resulting in euphoria (Uhl et al., 2019). Therefore, repeated opioid use can affect the brain’s reward system, leading to increased drug cravings and a diminished ability to enjoy pleasure from other activities. These brain changes can be long-lasting, making it difficult to break the addiction cycle.
Prescription and Illicit Opioids
Prescription opioids are routinely used to relieve pain, and while they can be beneficial, they can also be very addictive. Stoicea et al. (2019) state that around 100 million people suffered from pain in 2016. Similarly, Saloner et al. (2018) report that according to the National Survey of Drug Use and Health, up to 92 million people used pain relievers, while 2.1 million had opioid use disorder symptoms. For instance, opioids like oxycodone and hydrocodone can cause physical dependency, tolerance, and withdrawal symptoms, all of which can lead to addiction (Stoicea et al., 2019). Individuals may abuse prescription opioids in some situations by taking greater dosages or taking them more frequently than prescribed, increasing the risk of addiction.
Illicit opioids, such as heroin and fentanyl, are frequently less expensive and more powerful than prescribed opioids. Thus, they have a higher risk of causing overdose and addiction. For example, Saloner et al. (2018) found that 0.9 million people had heroin addiction in 2016. Vadivelu et al. (2018) state that an increase in death rates is linked to uncontrolled and illegal production of fentanyl.
Stoicea et al. (2019) reported that fentanyl, in line with other synthetic opioids, caused 19,000 deaths in 2016, more than other types of opioids. It has been observed that many people who get addicted to opioids begin by abusing prescription painkillers, whether for valid medical reasons or non-medical ones. When addicted, some people switch to illicit opiates like heroin because they are less expensive and easier to obtain.
Treatment Options for Opioid Addiction
Medication-Assisted Treatment
Medication-assisted therapy (MAT) is an evidence-based method of opioid addiction treatment that combines drugs with behavioral treatments. It has been found that methadone and buprenorphine are typical medications used to treat opioid addiction (Blanco et al., 2020; Kleber, 2022). These drugs function by reducing mortality, opioid usage, HIV and hepatitis C virus transmission, and increasing treatment adherence (Schranz et al., 2018).
Intramuscular naltrexone is less thoroughly studied and more difficult to start than opioid agonists due to the requirement to abstain for about one week before the first dosage (Sofuoglu et al., 2018). However, among those who begin taking naltrexone, it has been shown to reduce opioid use and craving (Kleber, 2022; Sofuoglu et al., 2018). MAT has been demonstrated to reduce illicit opioid usage, improve treatment retention, and lower the risk of overdose.
Behavioral Therapies
Behavioral treatments are an important part of addiction therapy and can be used with medication-assisted treatment. Cognitive-behavioral therapy (CBT), contingency management, and motivational interviewing are all behavioral therapies that can help people develop coping skills, identify and address drug-use triggers, and enhance their decision-making abilities (Kakko et al., 2019). CBT is helpful as part of therapy regimens aimed at preventing relapses (Kakko et al., 2019). Moreover, Sofioglu et al. (2018) state that when administered in the context of MAT, behavioral treatments’ functions have increased drug adherence, addressed components of the condition not addressed by pharmacotherapy, and addressed particular pharmacotherapy deficiencies. These therapies can also help with co-occurring mental health issues, including sadness and anxiety.
Prevention Strategies for Opioid Addiction
Preventing opioid addiction requires addressing the underlying reasons for addiction. The entire impact of opioids on the US healthcare infrastructure is projected to be $72.5 billion per year (Stoicea et al., 2019). Vadivelu et al. (2018) emphasize the importance of continuing to support measures to combat the opioid epidemic. They point out the importance of employing prescription-drug monitoring programs and improving their prescribing procedures to reduce the danger of opioid misuse.
In a similar sense, Lim et al. (2022) suggested that the SOURCE model track the US opioid-using population. Using the model, the authors identified two dynamic factors influencing the issue: social influence and risk perception (Lim et al., 2022). Social determinants of health, such as poverty, unemployment, and a lack of access to healthcare, may be among the other underlying causes.
Prevention initiatives should prioritize addressing these underlying concerns through policies and programs that enhance economic stability, healthcare access, and social support (Volkow, 2019). Thus, Jalali et al. (2020) also argue that tackling the opioid crisis requires a comprehensive, systems-level approach that considers the intricate interaction of variables contributing to the epidemic. Meanwhile, Blanco et al. (2020) emphasize the need to tackle the factors influencing health, including poverty, joblessness, and limited healthcare access, contributing to the opioid problem.
In addition to these interventions, according to Saloner et al. (2018), education and awareness campaigns are also a strong approach to managing the problem. It is critical to explain to patients that some pain is expected following medical interventions and to discuss the risks of taking certain medications (Saloner et al., 2018). Besides, educating medical workers can also be an important part of this intervention. The doctors and nurses should know how to better integrate addiction medicine for some patients who may suffer from chronic pain. Overall, the education process should provide both patients and staff with information on the hazards and consequences of opioid use, and information about safe pain management strategies can also help avoid opioid addiction.
Implications
One of the most significant consequences of the opioid crisis is the need for more research funding to better understand the complex dynamics of the epidemic and create more effective preventive and treatment solutions. This study should concentrate on the socioeconomic determinants of health that contribute to the pandemic, as well as the neurobiological and psychological mechanisms that underpin addiction. Future research must continue to develop and test creative preventive and treatment techniques that account for the complex dynamics of the opioid crisis. This might include employing systems science research approaches as well as developing novel pharmacological and non-pharmacological opioid addiction therapies.
Conclusion
To summarize, the opioid pandemic is one of the most important public health issues of our day. The pandemic has underlined the importance of a comprehensive, evidence-based response involving a wide range of stakeholders and sectors, including healthcare, public health, law enforcement, and government. It has also emphasized the significance of addressing the root socioeconomic determinants of health that lead to addiction and drug use disorders.
References
Blanco, C., Wiley, T. R. A., Lloyd, J. J., Lopez, M. F., & Volkow, N. D. (2020). America’s opioid crisis: the need for an integrated public health approach. Translational Psychiatry, 10. Web.
Jalali, M. S., Botticelli, M., Hwang, R. C., Koh, H. K., & McHugh, R. K. (2020). The opioid crisis: Need for systems science research. Health Research Policy and Systems, 18. Web.
Kakko, J., Alho, H., Baldacchino, A., Molina, R., Nava, F. A., & Shaya, G. (2019). Craving in opioid use disorder: From neurobiology to clinical practice. Frontiers Psychiatry, 10. Web.
Kleber, H. D. (2022). Pharmacologic treatments for opioid dependence: detoxification and maintenance options. Dialogues in Clinical Neuroscience, 9(4), 455-470. Web.
Lim, T. Y., Stringfellow, E. J., Stafford, C. A., DiGennaro, C., Homer, J. B., Wakeland, W., Eggers, S. L., Kazemi, R., Glos, L., Ewing, E. G., Bannister, C. B., Humphreys, K., Throckmorton, D. C., & Jalali, M. S. (2022). Modeling the evolution of the US opioid crisis for national policy development. Proceedings of the National Academy of Sciences, 119(23). Web.
Moningka, H., Lichenstein, S., & Yip, S. W. (2019). Current understanding of the neurobiology of opioid use disorder: An overview. Current Behavioral Neuroscience Reports, 6, 1-11. Web.
Saloner, B., McGinty, E. E., Beletsky, L., Bluthenthal, R., Beyrer, C., Botticelli, M., & Sherman, S. G. (2018). A public health strategy for the opioid crisis. Public Health Reports, 133(1), 24S-25S. Web.
Schranz, A. J., Barrett, J., Hurt, C. B., Malvestutto, C., & Miller, W. C. (2018). Challenges facing a rural opioid epidemic: Treatment and prevention of HIV and Hepatitis C. Current HIV/AIDS Reports, 15, 245-254. Web.
Sofuoglu, M., DeVito, E. E., Carroll, K. M. (2018). Pharmacological and behavioral treatment of opioid use disorder. Psychiatric Research & Clinical Practice, 1(1), 4-15. Web.
Stoicea, N., Costa, A., Periel, L., Uribe, A., Weaver, T., & Bergese, S. D. (2019). Current perspectives on the opioid crisis in the US healthcare system. Medicine, 98(20). Web.
Uhl, G. R., Koob, G. F., & Cable, J. (2019). The neurobiology of addiction. ANNALS of the New York Academy of Sciences, 1451(1), 5-28. Web.
Vadivelu, N., Kai, A. M., Kodumudi, V., Sramcik, J., & Kaye, A. D. (2018). The opioid crisis: A comprehensive overview. Current Pain and Headache Reports, 22. Web.
Volkow, N. (2019). Addressing the socioeconomic complexities of addiction—lessons from the Kensington neighborhood in Philadelphia. National Institute on Drug Abuse. Web.